You are here

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Pubmed ID: 
26859455
Year: 
2016
Month: 
FEB
Volume: 
29
Issue: 
2
Citation: 
Lalaoui N, Hänggi K, Brumatti G, Chau D, Nguyen NY, Vasilikos L, Spilgies LM, Heckmann DA, Ma C, Ghisi M, Salmon JM, Matthews GM, de Valle E, Moujalled DM, Menon MB, Spall SK, Glaser SP, Richmond J, Lock RB, Condon SM, Gugasyan R, Gaestel M, Guthridge M, Johnstone RW, Munoz L, Wei A, Ekert PG, Vaux DL, Wong WW, Silke J. Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics. Cancer cell 29 (2) : 145 - 58(2016) PubMed (Grant IDs: 1016647, 461221, 1016701, 1025594, 1046984, 1046010, 1025239, 637367, 1008131, 1081221, 1051235, 1057905)